We noticed that one of the mechanisms of the anti‐fibrotic drug, Pirfenidone, for treating idiopathic pulmonary fibrosis is its inhibitory effect on TGF‐β signalling pathway.44 The gene discussed is TGFB1; the disease is pulmonary fibrosis.